SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-08-004520
Filing Date
2008-04-23
Accepted
2008-04-23 16:49:44
Documents
3
Period of Report
2008-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y55305e8vk.htm 8-K 24607
2 EX-2.1: AGREEMENT AND PLAN OF MERGER y55305exv2w1.htm EX-2.1 335269
3 EX-4.1: FORM OF TENDER AND STOCKHOLDER SUPPORT AGREEMENT y55305exv4w1.htm EX-4.1 46195
  Complete submission text file 0000950123-08-004520.txt   407720
Mailing Address SUITE 104 790 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address SUITE 104 790 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-252-6920
Sirtris Pharmaceuticals, Inc. (Filer) CIK: 0001388775 (see all company filings)

IRS No.: 201410189 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33465 | Film No.: 08772229
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1